Long-term survivors with immunotherapy in advanced NSCLC: is 'cure' within reach?
Transl Cancer Res
.
2020 Feb;9(2):409-414.
doi: 10.21037/tcr.2019.12.82.
Authors
Sara Monteverdi
1
,
Emanuele Vita
2
,
Giulia Sartori
1
,
Miriam Grazia Ferrara
2
,
Ettore D'Argento
3
,
Giampaolo Tortora
2
3
,
Michele Milella
1
,
Emilio Bria
#
2
3
,
Sara Pilotto
#
1
Affiliations
1
U.O.C. Oncology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
2
Medical Oncology, Università Cattolica del Sacro Cuore, Roma, Italy.
3
Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.
#
Contributed equally.
PMID:
35117384
PMCID:
PMC8798740
DOI:
10.21037/tcr.2019.12.82
No abstract available
Publication types
Editorial
Comment